+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Self-amplifying RNA Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom Synthesis Services), Application (Therapeutics Development, Biomedical Research) by End Use, Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 6085784
The Self-amplifying RNA Synthesis Market was valued at USD 110.1 Million in 2024, and is projected to reach USD 310.8 Million by 2030, rising at a CAGR of 19.24%. This expansion is largely driven by the increasing demand for RNA-based vaccines and therapies, particularly during the COVID-19 pandemic. Researchers are turning to saRNA as a promising platform for rapid vaccine development due to its ability to induce a stronger immune response. The self-amplification feature of RNA allows for lower dosages and potentially fewer side effects, which is gaining traction in clinical trials. As a result, pharmaceutical companies are focusing on incorporating saRNA into their product pipelines, further boosting market growth.

The growing interest in personalized medicine is another key factor contributing to the market's expansion. With advancements in genomic technologies, there is an increasing need for tailored treatments targeting specific genetic profiles. Self-amplifying RNA technologies enable the development of vaccines and gene therapies that can be customized for individual patients. Furthermore, as healthcare systems shift toward more personalized care, the demand for innovative solutions such as saRNA will continue to rise.

In addition, the global rise in infectious diseases and the urgent need for new therapeutic options create a favorable environment for saRNA technologies. Beyond vaccines, self-amplifying RNA is being explored for various diseases, including cancer, genetic disorders, and autoimmune diseases. The ability of saRNA to be engineered for different applications allows for diverse therapeutic options, attracting substantial investment from the public and private sectors. Moreover, the ongoing advancements in RNA technology and the increasing number of clinical trials are expected to accelerate market adoption. This growing interest in multi-disease applications ensures a promising outlook for the global self-amplifying RNA synthesis market in the coming years.

Self-amplifying RNA Synthesis Market Report Highlights

  • Based on product & service, the custom synthesis services segment is expected to witness the fastest growth rate during the forecast period, due to the increasing demand for tailored RNA solutions, which are essential in the development of personalized medicines and RNA-based therapeutics.
  • Based on an application, the therapeutics development segment dominated the market and accounted for the largest revenue share in 2024, driven by the surge in research and development of RNA-based therapeutics, such as vaccines and gene-editing tools, which have significantly contributed to the growth of this segment.
  • Based on end use, the pharmaceutical & biotechnology companies segment held the largest revenue share in 2024. These companies are in charge of RNA therapeutic research, product development, and large-scale production, thus creating a substantial demand for RNA synthesis services. Their significant investments in RNA technology, particularly for vaccine production and genetic therapies, have positioned them as major players in the market. The growing number of RNA-based therapies in development, including novel vaccines and gene therapies, ensures that these companies remain the primary end-users of RNA synthesis solutions.
  • Based on region, North America held the largest revenue share in 2024 in the self-amplifying RNA synthesis market, primarily driven by the region's strong pharmaceutical and biotechnology industries. The U.S. continues to lead RNA technology research, with significant investments in RNA-based therapeutics and vaccine development.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Service
1.2.2. Application
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Self-Amplifying RNA Synthesis Market Variables & Trends
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in RNA Technology
3.2.1.2. Rising Demand for Personalized Medicine
3.2.2. Market restraint analysis
3.2.2.1. Manufacturing and Scalability Challenges
3.2.2.2. Regulatory and Scientific Hurdles
3.3. Self-Amplifying RNA Synthesis Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Self-Amplifying RNA Synthesis Market: Product & Service Estimates & Trend Analysis
4.1. Product & Service Segment Dashboard
4.2. Global Self-Amplifying RNA Synthesis Market Product & Service Movement Analysis
4.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Products
4.4.1. Products Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
4.4.2. Premade saRNA
4.4.2.1. Premade saRNA Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
4.4.3. Enzymes & Reagents
4.4.3.1. Enzymes & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
4.5. Custom Synthesis Services
4.5.1. Custom Synthesis Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
Chapter 5. Self-Amplifying RNA Synthesis Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Global Self-Amplifying RNA Synthesis Market Application Movement Analysis
5.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Therapeutics Development
5.4.1. Therapeutics Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
5.4.2. Infectious Diseases
5.4.2.1. Infectious Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
5.4.3. Oncology
5.4.3.1. Oncology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
5.5. Biomedical Research
5.5.1. Biomedical Research Techniques Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
Chapter 6. Self-Amplifying RNA Synthesis Market: End Use Estimates & Trend Analysis
6.1. End Use Segment Dashboard
6.2. Global Self-Amplifying RNA Synthesis Market End Use Movement Analysis
6.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
6.6. Other End Use
6.6.1. Other End Use Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
Chapter 7. Self-Amplifying RNA Synthesis Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Company Market Position Analysis, 2024
8.3. Strategy Mapping
8.4. Participants Overview
8.4.1. GenScript
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product & Service benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Creative Biogene
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product & Service benchmarking
8.4.2.4. Strategic initiatives
8.4.3. OZ Biosciences
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product & Service benchmarking
8.4.3.4. Strategic initiatives
8.4.4. BOC Sciences
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product & Service benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Croyez Bioscience Co., Ltd.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product & Service benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Creative Biolabs
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product & Service benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Maravai LifeSciences
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product & Service benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Areterna LLC
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product & Service benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Applied DNA Sciences, Inc. (LineaRx)
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product & Service benchmarking
8.4.9.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America Self-Amplifying RNA Synthesis Market, by Country, 2018-2030 (USD Million)
Table 3 North America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 4 North America Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 5 North America Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 6 U.S. Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 7 U.S. Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 8 U.S. Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 9 Canada Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 10 Canada Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 11 Canada Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 12 Mexico Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 13 Mexico Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 14 Mexico Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 15 Europe Self-Amplifying RNA Synthesis Market, by Country, 2018-2030 (USD Million)
Table 16 Europe Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 17 Europe Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 18 Europe Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 19 UK Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 20 UK Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 21 UK Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 22 Germany Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 23 Germany Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 24 Germany Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 25 Italy Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 26 Italy Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 27 Italy Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 28 France Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 29 France Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 30 France Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 31 Spain Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 32 Spain Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 33 Spain Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 34 Sweden Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 35 Sweden Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 36 Sweden Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 37 Denmark Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 38 Denmark Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 39 Denmark Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 40 Norway Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 41 Norway Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 42 Norway Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 43 Asia Pacific Self-Amplifying RNA Synthesis Market, by Country, 2018-2030 (USD Million)
Table 44 Asia Pacific Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 45 Asia Pacific Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 46 Asia Pacific Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 47 China Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 48 China Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 49 China Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 50 Japan Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 51 Japan Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 52 Japan Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 53 India Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 54 India Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 55 India Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 56 South Korea Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 57 South Korea Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 58 South Korea Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 59 Australia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 60 Australia Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 61 Australia Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 62 Thailand Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 63 Thailand Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 64 Thailand Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 65 Latin America Self-Amplifying RNA Synthesis Market, by Country, 2018-2030 (USD Million)
Table 66 Latin America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 67 Latin America Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 68 Latin America Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 69 Brazil Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 70 Brazil Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 71 Brazil Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 72 Argentina Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 73 Argentina Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 74 Argentina Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 75 Middle East Africa Self-Amplifying RNA Synthesis Market, by Country, 2018-2030 (USD Million)
Table 76 Middle East Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 77 Middle East Africa Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 78 Middle East Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 79 South Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 80 South Africa Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 81 South Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 82 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 83 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 84 Saudi Arabia Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 85 UAE Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 86 UAE Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 87 UAE Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
Table 88 Kuwait Self-Amplifying RNA Synthesis Market, by Product & Service, 2018-2030 (USD Million)
Table 89 Kuwait Self-Amplifying RNA Synthesis Market, by Application, 2018-2030 (USD Million)
Table 90 Kuwait Self-Amplifying RNA Synthesis Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-Chain-Based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market formulation & Validation
Figure 8 Self-Amplifying RNA Synthesis Market: Market Outlook
Figure 9 Parent Market Outlook
Figure 10 Related/Ancillary Market Outlook
Figure 11 Penetration and Growth Prospect Mapping
Figure 12 Industry Value Chain Analysis
Figure 13 Self-Amplifying RNA Synthesis Market Driver Impact
Figure 14 Self-Amplifying RNA Synthesis Market Restraint Impact
Figure 15 Self-Amplifying RNA Synthesis Market Strategic Initiatives Analysis
Figure 16 Self-Amplifying RNA Synthesis Market: Product & Service Movement Analysis
Figure 17 Self-Amplifying RNA Synthesis Market: Product & Service Outlook and Key Takeaways
Figure 18 Products Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 19 Premade saRNA Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 20 Enzymes & Reagents Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 21 Others Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 22 Custom Synthesis Services Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 23 Self-Amplifying RNA Synthesis Market: Application Movement Analysis
Figure 24 Self-Amplifying RNA Synthesis Market: Application Outlook and Key Takeaways
Figure 25 Therapeutics Development Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Infectious Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Biomedical Research Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Self-Amplifying RNA Synthesis Market: End-Use Movement Analysis
Figure 31 Self-Amplifying RNA Synthesis Market: End-Use Outlook and Key Takeaways
Figure 32 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Academic & Research Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Other End Use Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Global Self-Amplifying RNA Synthesis Market: Regional Movement Analysis
Figure 36 Global Self-Amplifying RNA Synthesis Market: Regional Outlook and Key Takeaways
Figure 37 North America Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 U.S. Country Dynamics
Figure 39 U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Canada Country Dynamics
Figure 41 Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Mexico Country Dynamics
Figure 43 Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 UK Country Dynamics
Figure 46 UK Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Germany Country Dynamics
Figure 48 Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 France Country Dynamics
Figure 50 France Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Italy Country Dynamics
Figure 52 Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Spain Country Dynamics
Figure 54 Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Denmark Country Dynamics
Figure 56 Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Sweden Country Dynamics
Figure 58 Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Norway Country Dynamics
Figure 60 Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 China Country Dynamics
Figure 63 China Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Japan Country Dynamics
Figure 65 Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 India Country Dynamics
Figure 67 India Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Thailand Country Dynamics
Figure 69 Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 South Korea Country Dynamics
Figure 71 South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 Australia Country Dynamics
Figure 73 Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 75 Brazil Country Dynamics
Figure 76 Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 77 Argentina Country Dynamics
Figure 78 Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 79 Middle East and Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 80 South Africa Country Dynamics
Figure 81 South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 82 Saudi Arabia Country Dynamics
Figure 83 Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 84 UAE Country Dynamics
Figure 85 UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 86 Kuwait Country Dynamics
Figure 87 Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 88 Market Position of Key Market Players

Companies Mentioned

The companies profiled in this Self-amplifying RNA Synthesis market report include:
  • GenScript
  • Creative Biogene.
  • OZ Biosciences
  • BOC Sciences
  • Croyez Bioscience Co., Ltd.
  • Creative Biolabs.
  • Maravai LifeSciences
  • Areterna LLC
  • Applied DNA Sciences, Inc. (LineaRx)

Methodology

Loading
LOADING...

Table Information